2146 Results

People

  1. Aghajanian
    Aghajanian
  2. Hensley
    Hensley
  3. Abu-Rustum
    Abu-Rustum
  4. O'Cearbhaill
    O'Cearbhaill
  5. Makker
    Makker
  6. Tew
    Tew
  7. Lichtman
    Lichtman
  8. Zamarin
    Zamarin
  9. Chi
    Chi
  10. Iasonos
    Iasonos

Groups

  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)
  7. GDMT, Surgery (474)
  8. Epidemiology and Biostatistics (398)
  9. Department of Pathology and Laboratory Medicine (395)
  10. Survivorship Research (390)
  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes
    Meeting Abstract

    Gordhandas, S.; Manning-Geist, B.; Hodgson, A.; Zhou, Q.; Iasonos, A.; Chi, D.; Momeni-Boroujeni, A.; Abu-Rustum, N.; Leitao, M.; Roche, K. L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Overall survival results from Ariel3: A phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma
    Meeting Abstract

    Coleman, R. L.; Oza, A.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Endogenous retrotransposable elements induction in SMARCA4-deficient ovarian cancer is associated with immunomodulatory changes in the tumor microenvironment
    Meeting Abstract

    Brodeur, M. N.; Sun, S.; Zhu, Y.; Greenbaum, B.; Weigelt, B.; Zamarin, D.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab versus treatment of physician's choice in patients with previously treated advanced endometrial cancer: Study 309/KEYNOTE-775 Asian subgroup
    Meeting Abstract

    Yonemori, K.; Fujiwara, K.; Hasegawa, K.; Yunokawa, M.; Ushijima, K.; Suzuki, S.; Shikama, A.; Minobe, S.; Usami, T.; Kim, J. W.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial
    Meeting Abstract

    Park, J. O.; Meng, D. T. W.; Hollebecque, A.; Borad, M.; Goyal, L.; Schram, A.; Cassier, P.; Kamath, S. D.; Dotan, E.; Kim, R.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival data from a 3-arm, randomized, open-label, phase 2 study of relacorilant, a selective glucocorticoid receptor modulator, combined with nab-paclitaxel in patients with recurrent platinum-resistant ovarian cancer
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U. A.; Oaknin, A.; Grisham, R. N.; Fleming, G. F.; Olawaiye, A.; Pashova, H. I.; Nguyen, D. D.; Lorusso, D.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Chi, D.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; O'Cearbhaill, R.; Zivanovic, O.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Oncologic outcomes of secondary cytoreductive surgery in the era of poly (ADP-ribose) polymerase inhibitors maintenance
    Meeting Abstract

    Ehmann, S.; Lam, C.; Zhou, Q.; Grisham, R.; Roche, K. L.; Zivanovic, O.; Sonoda, Y.; Chi, D.; Gardner, G.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both?
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Glaser, G.; McGree, M.; Eriksson, A. G. Z.; Pham, M.; Soliman, P.; Ataseven, B.; Alektiar, K.; Zamarin, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save